Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎ New York, NY

(646) 856-9261

info@rgenix.com

Our Company
Our Technology
- Presentations & Publications
Pipeline
- Overview
- RGX-104
- RGX-202
- RGX-019
Patients
Investors
News

Our Company
Our Technology
- Presentations & Publications
Pipeline
- Overview
- RGX-104
- RGX-202
- RGX-019
Patients
Investors
News

Our Company
Our Technology
- Presentations & Publications
Pipeline
- Overview
- RGX-104
- RGX-202
- RGX-019
Patients
Investors
News

Rgenix

H.C. Wainwright 22nd Annual Global Investment Conference

September 21, 2020

H.C. Wainwright 22nd Annual Global Investment Conference

Listen to the replay

Related posts

Rgenix-lab-new-york

November 23, 2020

RGENIX to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference

November 4, 2020

RGENIX to Present at 2020 Stifel Virtual Healthcare Conference

September 2, 2020

RGENIX to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Categories

Events (41)
News (37)
Press Releases (19)

Recent News

RGENIX to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference November 23, 2020
RGENIX to Present at 2020 Stifel Virtual Healthcare Conference November 4, 2020
H.C. Wainwright 22nd Annual Global Investment Conference September 21, 2020
RGENIX to Present at H.C. Wainwright 22nd Annual Global Investment Conference September 2, 2020
Canaccord Genuity 40th Annual Growth Conference August 11, 2020

Tags

AACR AACR Meeting ApoE ARMO Biosciences ASCO Atlanta biopharmaceutical company biotech Board of Directors Cancer Patients Chief Medical Officer Conference David Darst genomics Immuno-Oncology Immunotherapy Isabel Kurth LXR LXR/ApoE LXR/ApoE pathway Masoud Tavazoie microRNA monotherapy Nilesh Kumar oncology Peter Van Vlasselaer RGX-104 RGX-202 Robert Wasserman Rockefeler University Roger Waltzman Sofinnova Partners

Search for:

Twitter Feed

Missed our CEO, Dr. Masoud Tavazoie, presenting at the 2020 RBC Capital Markets #Healthcare Private Company Confere… https://t.co/CjK0f4Z4lg 4 months ago
Don’t miss our CEO, Dr. Masoud Tavazoie, presenting at the 2020 RBC Capital Markets #Healthcare Private Company Con… https://t.co/XVtkm4tIaE 4 months ago

Rgenix

News
Investors
Patients
Careers
Contact us

Newsletter

Privacy Policy Terms of Use